Increased β-Thromboglobulin in Essential Hypertension: Interactions between Arterial Plasma Adrenaline, Platelet Function and Blood Lipids

2009 ◽  
Vol 213 (5) ◽  
pp. 369-373 ◽  
Author(s):  
Sverre Erik Kjeldsen ◽  
Knut Gjesdal ◽  
Ivar Eide ◽  
Ingvar Aakesson ◽  
Ruth Amundsen ◽  
...  
Cardiology ◽  
1993 ◽  
Vol 82 (6) ◽  
pp. 399-404 ◽  
Author(s):  
Anna Okrucká ◽  
Jozef Pecháň ◽  
Ivan Balažovjech

1993 ◽  
Vol 11 (5) ◽  
pp. 559-564 ◽  
Author(s):  
Faiez Zannad ◽  
Laure Bray-Desboscs ◽  
Raghida El Ghawi ◽  
Mireille Donner ◽  
Emmanuel Thibout ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Blanca Estela Ríos-González ◽  
Bertha Ibarra-Cortés ◽  
Guadalupe Ramírez-López ◽  
José Sánchez-Corona ◽  
María Teresa Magaña-Torres

Hypertension and dyslipidemia exhibit an important clinical relationship because an increase in blood lipids yields an increase in blood pressure (BP). We analyzed the associations of seven polymorphisms of genes involved in lipid metabolism (APOA5rs3135506,APOBrs1042031,FABP2rs1799883,LDLRrs5925,LIPCrs1800588,LPLrs328, andMTTPrs1800591) with blood pressure and lipid values in Mexican hypertensive (HT) patients. A total of 160 HT patients and 160 normotensive individuals were included. Genotyping was performed through PCR-RFLP, PCR-AIRS, and sequencing. The results showed significant associations in the HT group and HT subgroups classified as normolipemic and hyperlipemic. The allelesFABP2p.55T,LIPC−514T, andMTTP−493T were associated with elevated systolic BP. Five alleles were associated with lipids.LPLp.474X andFABP2p.55T were associated with decreased total cholesterol and LDL-C, respectively;APOA5p.19W with increased HDL-C;APOA5p.19W andFABP2p.55T with increased triglycerides; andAPOBp.4181K andLDLRc.1959T with decreased triglycerides. TheAPOBp.E4181K polymorphism increases the risk for HT (OR = 1.85, 95% CI: 1.17–2.93;P=0.001) under the dominant model. These findings indicate that polymorphisms of lipid metabolism genes modify systolic BP and lipid levels and may be important in the development of essential hypertension and dyslipidemia in Mexican HT patients.


1989 ◽  
Vol 118 (4) ◽  
pp. 775-781 ◽  
Author(s):  
Sverre E. Kjeldsen ◽  
Nicholas J. Schork ◽  
Paul Leren ◽  
Ivar K. Eide

1985 ◽  
Vol 54 (02) ◽  
pp. 450-453 ◽  
Author(s):  
K Lande ◽  
K Gjesdal ◽  
E Fønstelien ◽  
S E Kjeldsen ◽  
I Eide

SummaryAt the end of a diagnostic right heart catheterization ten patients received an intravenous infusion of l-adrenaline which gradually increased the arterial plasma adrenaline concentration from resting physiological values to high values as seen during myocardial infarction, pheochromocytoma and hypoglycemia. Blood was sampled from the brachial artery, femoral vein and hepatic vein. During the adrenaline infusion venous beta-thromboglobulin concentrations increased 23% from 61 ± 5 to 80 ± 7 μg/l (mean ± SE), arterial platelet counts 20% from 212 ± 17 to 253 ± 25 × 109/l and arterial platelet volume 4% from 7.25 ± 0.20 to 7.56 ± 0.21 femtoliter. All changes were significant at the 5% level. Thus, acute increments of arterial plasma adrenaline significantly stimulated the blood platelet parameters studied.


Sign in / Sign up

Export Citation Format

Share Document